News
2022/11/10Francesco Chiampo our long-term partner from the Centro San Girolamo shared the incredible and powerful story of Christophers journey to recovery after a devastating accident on TED x Mantova using life changing HAL technology. In his own words he said he fell in love with HAL (Hybrid Assistive Limb) because HAL was the answer to his questions: "How can I help patients? How can I help people who have become patients? The patient is a person who is not disease, but the patient is a person who has lost some of his function but still have residual potentials."
Full talk here: Un passo dopo l'altro, di nuovo in cammino | Francesco Chiampo | TEDxMantova - YouTube
The author:
Francesco Chiampo Founder of Centro San Girolamo, an experienced professional with two physiotherapy degrees and a master's degree in healthcare management behind him, Francesco was first Head of Physiotherapy Triage, then Quality Manager and finally Rehabilitation Area Manager at the Don Gnocchi Foundation in Parma. In 2013, he founded Centro San Girolamo, a landmark rehabilitation center specializing in neurorehabilitation. Francesco is also co-author of several scientific publications.
More about Centro San Girolamo:
Il futuro della riabilitazione | Centro San Girolamo
HAL technology:
HAL (Hybrid Assisted Limb) is the world’s first neurological controlled Wearable Cyborg by which a wearers physical functions can be improved and regenerated. By detecting small bioelectrical signals on the skin from the muscles, the device creates a biofeedback loop back to the brain to facilitate learning of movement. Its neurological control distinguishes it from other exoskeletons, and it is used for neuromuscular feedback training in patients with neurogenic movement disorders.
Movements are triggered by signals sent from the brain to the muscle via the spinal cord. In response to the signal, the muscle tenses and the movement is executed. The signals for movement initiation, hereinafter referred to as bioelectric signals (BES for short), can be recorded on the surface of the skin using electrodes. In patients with neurogenic movement disorders, this signal chain is impaired, so that the patient's own movement initiation is only possible to a limited extent.
Contact:
Motoaki Komiya
CEO
+49 234 587300 7007
+49 174 4097030